Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily targets lipid-
producing cells for viral tropism. In this review, we connect systemic lipid couriers …

ABSTRACT BACKGROUND Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-
2) is the infectious agent responsible for Coronavirus disease 2019 (COVID-19). While …

Background and aims The number of positive and death cases from coronavirus disease
2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is …

The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates
and worse prognosis in individuals with underlying chronic diseases, especially …

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection leads to the
development of coronavirus disease 2019 (COVID-19), which causes endothelial …

Introduction A small percentage of patients will develop a severe form of COVID-19 caused
by SARS-CoV-2 infection. Thus, it is important to predict the potential outcomes identifying …

Polyunsaturated fatty acids are metabolized into regulatory lipids important for initiating
inflammatory responses in the event of disease or injury and for signaling the resolution of …

Background COVID-19 patients develop hypolipidemia. However, it is unknown whether
lipid levels have improved and there are potential sequlae in recovered patients. Objective …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to
nearly every continent, registering over 1,250,000 deaths worldwide. The effects of SARS …

Abstract Lipoprotein (a)(Lp (a)) is a prothrombotic and anti-fibrinolytic lipoprotein, whose role
has not been clearly defined in the pathogenesis of coronavirus disease 2019 (COVID-19) …